Discovery and Characterization of a Novel HCV Inhibitor Targeting the Late Stage of HCV Life Cycle
Seung Bum Park(National Institutes of Health), T. Jake Liang(National Institutes of Health), Audrey Boyer(Université de Tours), Zongyi Hu(National Institutes of Health), Derek J. Le(National Institutes of Health)
Cited by 5
Related Papers
Host Response to Translocated Microbial Products Predicts Outcomes of Patients With HBV or HCV Infection
|Gastroenterology|2011|310
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner
|Gastroenterology|2009|271
Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal–Oral Transmission? A COVID-19 Virological and Clinical Review
|Gastroenterology|2020|223
Pathogenesis of hepatitis C—associated hepatocellular carcinoma
|Gastroenterology|2004|218